Used in biomedical research to quantify levels of soluble urokinase-type plasminogen activator receptor (suPAR) in biological samples such as serum, plasma, and cell culture supernatants. The kit enables researchers to study the role of uPAR in processes involving cell adhesion, migration, and tissue remodeling, which are critical in inflammation, cancer progression, and metastasis. It is widely applied in studies related to immune activation, infectious diseases, and chronic conditions like diabetes and cardiovascular diseases. The assay supports early detection of disease states, monitoring of therapeutic responses, and validation of uPAR as a biomarker in clinical and preclinical settings.